1973 - Volume 15, Issue 2 | by Masironi, R. (World Health Organization, Cardiovascular Diseases Unit, Geneva (CH) Parr, R.M. (International Atomic Energy Agency, Medical Applications Section, Vienna (AT))
For the past four years the World Health Organization and the International Atomic Energy-Agency have been jointly coordinating investigations at an international level on the role possibly played by stable trace elements in the aetiology of cardiovascular diseases, and the use
... Read more »
|
1973 - Volume 15, Issue 2 | by Shalmon, E. (World Health Organization, Geneva (CH))
A continuing rapid growth of the nuclear industry is anticipated in the near future. Estimates indicate that of the various peaceful applications of nuclear energy, power production systems including the fuel cycle have become the largest potential source of environmental
... Read more »
|
1973 - Volume 15, Issue 2 | by Rothchild, S. (International Atomic Energy Agency, Division of Research and Laboratories, Vienna (AT))
Radioactive drugs, or radiopharmaceuticals, are used clinically for the diagnosis, investigation and occasionally for the therapy, of many human illnesses. he first radiopharmaceutical to be widely used was the fission product, iodine-131, in the form of the simple salt, sodium
... Read more »
|
1973 - Volume 15, Issue 2 | by Wallen, O. Komarov, E. (World Health Organization, Geneva (CH))
The International Pharmacopoeia published by WHO constitutes a collection of recommended specifications for pharmaceutical preparations which are not intended to have legal status in any country, but serve as references so that national specifications can be established on a
... Read more »
|
1973 - Volume 15, Issue 2 | by Author not available
On the poetic Roskilde Fjord, 40 kilometers from Copenhagen, and near Roskilde, capital of Denmark in the 12th century, stands the Risoe Research Establishment of the Danish Atomic Energy Commission. ere 700 men and women are engaged in searching for ways in which atomic energy
... Read more »
|
1973 - Volume 15, Issue 2 | by Dudley, R.A. (International Atomic Energy Agency, Division of Research and Laboratories, Vienna (AT))
For many years, both the World Health Organization and the International Atomic Energy Agency have sponsored research related to the subject of iron deficiency in humans. About four years ago their collective efforts were brought into focus in a co-ordinated research programme
... Read more »
|
1973 - Volume 15, Issue 2 | by Eisenlohr, H. Abedin-Zadeh, R. (International Atomic Energy Agency, Vienna (AT))
In radiotherapy, more than in any other radiation application, dosimetry of maximum accuracy is essential. This is necessary to ensure effective treatment, and also to allow comparison of therapeutic methods and their results. It is, in fact, the most important aspect of
... Read more »
|
1973 - Volume 15, Issue 2 | by Author not available
In 1968, two years after the IAEA began its postal checking service to dosimetry laboratories, a panel meeting was held at Caracas with WHO participation. It was agreed that the complete absence of national laboratories for standardizing radiation measurements in most regions of
... Read more »
|
|
